127 related articles for article (PubMed ID: 11018526)
21. Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells.
Georg B; Riccio A; Andreasen P
Mol Cell Endocrinol; 1990 Aug; 72(2):103-10. PubMed ID: 1704320
[TBL] [Abstract][Full Text] [Related]
22. Requirement for cAMP-response element (CRE) binding protein/CRE modulator transcription factors in thyrotropin-induced proliferation of dog thyroid cells in primary culture.
Uyttersprot N; Costagliola S; Dumont JE; Miot F
Eur J Biochem; 1999 Jan; 259(1-2):370-8. PubMed ID: 9914516
[TBL] [Abstract][Full Text] [Related]
23. The species-specific differences in the cAMP regulation of the tissue-type plasminogen activator gene between rat, mouse and human is caused by a one-nucleotide substitution in the cAMP-responsive element of the promoters.
Holmberg M; Leonardsson G; Ny T
Eur J Biochem; 1995 Jul; 231(2):466-74. PubMed ID: 7543410
[TBL] [Abstract][Full Text] [Related]
24. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
25. The inducible cAMP early repressor ICERIIgamma inhibits CREB and AP-1 transcription but not AT1 receptor gene expression in vascular smooth muscle cells.
Wang X; Murphy TJ
Mol Cell Biochem; 2000 Sep; 212(1-2):111-9. PubMed ID: 11108142
[TBL] [Abstract][Full Text] [Related]
26. The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity.
Dear AE; Medcalf RL
Biochim Biophys Acta; 2000 Jun; 1492(1):15-22. PubMed ID: 11004477
[TBL] [Abstract][Full Text] [Related]
27. Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain.
Böer U; Eglins J; Krause D; Schnell S; Schöfl C; Knepel W
Biochem J; 2007 Nov; 408(1):69-77. PubMed ID: 17696880
[TBL] [Abstract][Full Text] [Related]
28. Regulation of plasminogen activators and type-1 plasminogen activator inhibitor by cyclic AMP and phorbol ester in rat astrocytes.
Tranque P; Robbins R; Naftolin F; Andrade-Gordon P
Glia; 1992; 6(3):163-71. PubMed ID: 1335967
[TBL] [Abstract][Full Text] [Related]
29. Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro.
Arts J; Herr I; Lansink M; Angel P; Kooistra T
Nucleic Acids Res; 1997 Jan; 25(2):311-7. PubMed ID: 9016559
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer.
Antalis TM; Costelloe E; Muddiman J; Ogbourne S; Donnan K
Blood; 1996 Nov; 88(10):3686-97. PubMed ID: 8916932
[TBL] [Abstract][Full Text] [Related]
31. Regulation of human tissue-type plasminogen activator gene transcription by epidermal growth factor and 3',5'-cyclic adenosine monophosphate.
Medcalf RL; Schleuning WD
Mol Endocrinol; 1991 Dec; 5(12):1773-9. PubMed ID: 1665201
[TBL] [Abstract][Full Text] [Related]
32. CRE DNA binding proteins bind to the AP-1 target sequence and suppress AP-1 transcriptional activity in mouse keratinocytes.
Rutberg SE; Adams TL; Olive M; Alexander N; Vinson C; Yuspa SH
Oncogene; 1999 Feb; 18(8):1569-79. PubMed ID: 10102627
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif.
Mahony D; Kalionis B; Antalis TM
Eur J Biochem; 1999 Aug; 263(3):765-72. PubMed ID: 10469140
[TBL] [Abstract][Full Text] [Related]
34. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
35. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
36. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
37. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
38. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured monkey Sertoli cells.
Liu YX; Liu K; Zhou HM; Du Q; Hu ZY; Zou RJ
Hum Reprod; 1995 Mar; 10(3):719-27. PubMed ID: 7540182
[TBL] [Abstract][Full Text] [Related]
39. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2.
Antalis TM; Godbolt D; Donnan KD; Stringer BW
Gene; 1993 Dec; 134(2):201-8. PubMed ID: 8262378
[TBL] [Abstract][Full Text] [Related]
40. Blockade of cyclic AMP-responsive element DNA binding in the brain of CREB delta/alpha mutant mice.
Pandey SC; Mittal N; Silva AJ
Neuroreport; 2000 Aug; 11(11):2577-80. PubMed ID: 10943725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
